News from calyxt, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 18, 2022, 11:00 ET Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil

Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its...

Nov 17, 2022, 16:01 ET Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Calyxt, Inc (Nasdaq: CLXT) a plant-based synthetic biology focused on engineering sustainable ingredients for customers in the cosmeceutical,...

Nov 03, 2022, 16:01 ET Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants— —Continued to progress customer...

Nov 01, 2022, 07:00 ET Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing

Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that it has become a member of Bioindustrial Manufacturing and...

Oct 27, 2022, 07:00 ET Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, November 3, 2022, at 4:30...

Oct 25, 2022, 07:00 ET Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that using a Calyxt-engineered Plant Cell Matrix™ biomass, it...

Oct 06, 2022, 07:00 ET Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that it has signed an agreement with its first manufacturing...

Sep 22, 2022, 07:00 ET Calyxt, Inc. Exploring Strategic Alternatives

Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt"), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential...

Sep 07, 2022, 07:00 ET Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer,...

Aug 04, 2022, 16:01 ET Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of ...

Jul 28, 2022, 07:00 ET Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, Chief Executive Officer, and Bill...

Jul 21, 2022, 07:00 ET Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30...

May 17, 2022, 07:00 ET Calyxt to Present at Upcoming Conferences

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upcoming...

May 05, 2022, 16:01 ET Calyxt Reports First Quarter 2022 Financial Results

...

Apr 26, 2022, 07:00 ET Calyxt Announces Strategic Hires in Business Development and Manufacturing

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, yesterday welcomed the second of two director-level hires in areas...

Apr 21, 2022, 07:08 ET Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m....

Mar 08, 2022, 07:00 ET Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in a fireside chat at the 34th ...

Mar 03, 2022, 16:01 ET Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced financial results for its fourth quarter and full year ended...

Feb 24, 2022, 07:00 ET Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will hold a conference call on Thursday, March 3, 2022, at 4:30 p.m. Eastern...

Feb 23, 2022, 16:05 ET Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock

Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt" or the "Company"), a plant-based synthetic biology company, today announced the closing of its previously...

Feb 17, 2022, 20:02 ET Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants

Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt" or the "Company"), a plant-based synthetic biology company, today announced the placement to an institutional...

Feb 07, 2022, 07:00 ET Calyxt Announces Gerry Nuovo as Senior Vice President of Business Development

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that Gerry Nuovo has joined Calyxt as Senior Vice...

Jan 06, 2022, 17:25 ET Calyxt Announces Pilot BioFactory™ Production System Now Operational

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that its pilot BioFactory™ production system, installed...

Jan 04, 2022, 07:00 ET Calyxt to Present at the H.C. Wainwright BioConnect Virtual Conference

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company today announced that a presentation given by management at the H.C...

Dec 08, 2021, 07:00 ET Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run

Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale...